Advanced glycation end products, oxidative stress and diabetic nephropathy - PubMed (original) (raw)
Review
Advanced glycation end products, oxidative stress and diabetic nephropathy
Sho-Ichi Yamagishi et al. Oxid Med Cell Longev. 2010 Mar-Apr.
Free PMC article
Abstract
About 246 million people worldwide have diabetes in 2007. The global figure of people with diabetes is projected to increase to 370 million in 2030. As the prevalence of diabetes has risen to epidemic proportions worldwide, diabetic nephropathy has become one of the most challenging health problems. Therapeutic options such as strict blood glucose and blood pressure controls are effective for preventing diabetic nephropathy, but are far from satisfactory, and the number of diabetic patients on end-stage renal disease is still increasing. Therefore, a novel therapeutic strategy that could halt the progression of diabetic nephropathy should be developed. There is accumulating evidence that advanced glycation end products (AGEs), senescent macroprotein derivatives formed at an accelerated rate under diabetes, play a role in diabetic nephropathy via oxidative stress generation. In this paper, we review the pathophysiological role of AGEs and their receptor (RAGE)-oxidative stress system in diabetic nephropathy.
Figures
Figure 1
Pathophysiological role of the AGE-RAGE axis in diabetic nephropathy.
Similar articles
- A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy.
Khanam A, Ahmad S, Husain A. Khanam A, et al. Curr Protein Pept Sci. 2023;24(1):2-6. doi: 10.2174/1389203724666221108120715. Curr Protein Pept Sci. 2023. PMID: 36366848 - Role of AGEs in diabetic nephropathy.
Fukami K, Yamagishi S, Ueda S, Okuda S. Fukami K, et al. Curr Pharm Des. 2008;14(10):946-52. doi: 10.2174/138161208784139710. Curr Pharm Des. 2008. PMID: 18473844 Review. - Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD. Tanji N, et al. J Am Soc Nephrol. 2000 Sep;11(9):1656-1666. doi: 10.1681/ASN.V1191656. J Am Soc Nephrol. 2000. PMID: 10966490 - AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D, Ghorbani Haghjo A, Argani H, Aslani S. Sanajou D, et al. Eur J Pharmacol. 2018 Aug 15;833:158-164. doi: 10.1016/j.ejphar.2018.06.001. Epub 2018 Jun 5. Eur J Pharmacol. 2018. PMID: 29883668 Review. - Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B, Qiang G, Zhao Y, Yang X, Chen X, Yan Y, Wang X, Liu C, Zhang L, Du G. Hou B, et al. Cell Physiol Biochem. 2017;44(6):2378-2394. doi: 10.1159/000486154. Epub 2017 Dec 18. Cell Physiol Biochem. 2017. PMID: 29262395
Cited by
- Can Meat and Meat-Products Induce Oxidative Stress?
Macho-González A, Garcimartín A, López-Oliva ME, Bastida S, Benedí J, Ros G, Nieto G, Sánchez-Muniz FJ. Macho-González A, et al. Antioxidants (Basel). 2020 Jul 20;9(7):638. doi: 10.3390/antiox9070638. Antioxidants (Basel). 2020. PMID: 32698505 Free PMC article. Review. - Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscle.
Mastrocola R, Collino M, Nigro D, Chiazza F, D'Antona G, Aragno M, Minetto MA. Mastrocola R, et al. PLoS One. 2015 Mar 9;10(3):e0119587. doi: 10.1371/journal.pone.0119587. eCollection 2015. PLoS One. 2015. PMID: 25750996 Free PMC article. - Serum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age.
Chiavaroli V, D'Adamo E, Giannini C, de Giorgis T, De Marco S, Chiarelli F, Mohn A. Chiavaroli V, et al. Diabetes Care. 2012 Jun;35(6):1361-3. doi: 10.2337/dc11-2302. Epub 2012 Apr 17. Diabetes Care. 2012. PMID: 22511256 Free PMC article. - Involvement of Endoplasmic Reticulum Stress, Autophagy, and Apoptosis in Advanced Glycation End Products-Induced Glomerular Mesangial Cell Injury.
Chiang CK, Wang CC, Lu TF, Huang KH, Sheu ML, Liu SH, Hung KY. Chiang CK, et al. Sci Rep. 2016 Sep 26;6:34167. doi: 10.1038/srep34167. Sci Rep. 2016. PMID: 27665710 Free PMC article. - _α_-Lipoic Acid Increases Collagen Synthesis and Deposition in Nondiabetic and Diabetic Rat Kidneys.
Grdović N, Rajić J, Arambašić Jovanović J, Dinić S, Tolić A, Đorđević M, Đorđević M, Trifunović S, Vidaković M, Uskoković A, Mihailović M. Grdović N, et al. Oxid Med Cell Longev. 2021 Mar 11;2021:6669352. doi: 10.1155/2021/6669352. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33777319 Free PMC article.
References
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
- Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145–1151. - PubMed
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853. - PubMed
- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–986. - PubMed
- Yamagishi S, Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 2005;11:2279–2299. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials